{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:24:19Z","timestamp":1793384659596,"version":"4.5.0"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology"],"published-print":{"date-parts":[[2012,1,10]]},"DOI":"10.1212\/wnl.0b013e31823efcf8","type":"journal-article","created":{"date-parts":[[2012,1,5]],"date-time":"2012-01-05T20:14:40Z","timestamp":1325794480000},"page":"139-145","source":"Crossref","is-referenced-by-count":80,"title":["Evidence-based guideline: Antiepileptic drug selection for people with HIV\/AIDS"],"prefix":"10.1212","volume":"78","author":[{"given":"G.L.","family":"Birbeck","sequence":"first","affiliation":[{"name":"From the International Neurologic & Psychiatric Epidemiology Program (G.L.B.), Michigan State University, East Lansing; Epilepsy Care Team, Chikankata Hospital (G.L.B.), Mazabuka, Zambia; NYU Comprehensive Epilepsy Center (J.A.F.), New York, NY; Clinical Pharmacology Unit (E.P.), University of Pavia and Institute of Neurology IRCCS C Mondino Foundation, Pavia, Italy; Department of Neurology (D.M.S.), Mount Sinai School of Medicine, New York, NY; Division of Infectious Diseases (H.F.), Cooper..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.","family":"French","sequence":"additional","affiliation":[{"name":"From the International Neurologic & Psychiatric Epidemiology Program (G.L.B.), Michigan State University, East Lansing; Epilepsy Care Team, Chikankata Hospital (G.L.B.), Mazabuka, Zambia; NYU Comprehensive Epilepsy Center (J.A.F.), New York, NY; Clinical Pharmacology Unit (E.P.), University of Pavia and Institute of Neurology IRCCS C Mondino Foundation, Pavia, Italy; Department of Neurology (D.M.S.), Mount Sinai School of Medicine, New York, NY; Division of Infectious Diseases (H.F.), Cooper..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Perucca","sequence":"additional","affiliation":[{"name":"From the International Neurologic & Psychiatric Epidemiology Program (G.L.B.), Michigan State University, East Lansing; Epilepsy Care Team, Chikankata Hospital (G.L.B.), Mazabuka, Zambia; NYU Comprehensive Epilepsy Center (J.A.F.), New York, NY; Clinical Pharmacology Unit (E.P.), University of Pavia and Institute of Neurology IRCCS C Mondino Foundation, Pavia, Italy; Department of Neurology (D.M.S.), Mount Sinai School of Medicine, New York, NY; Division of Infectious Diseases (H.F.), Cooper..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.M.","family":"Simpson","sequence":"additional","affiliation":[{"name":"From the International Neurologic & Psychiatric Epidemiology Program (G.L.B.), Michigan State University, East Lansing; Epilepsy Care Team, Chikankata Hospital (G.L.B.), Mazabuka, Zambia; NYU Comprehensive Epilepsy Center (J.A.F.), New York, NY; Clinical Pharmacology Unit (E.P.), University of Pavia and Institute of Neurology IRCCS C Mondino Foundation, Pavia, Italy; Department of Neurology (D.M.S.), Mount Sinai School of Medicine, New York, NY; Division of Infectious Diseases (H.F.), Cooper..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Fraimow","sequence":"additional","affiliation":[{"name":"From the International Neurologic & Psychiatric Epidemiology Program (G.L.B.), Michigan State University, East Lansing; Epilepsy Care Team, Chikankata Hospital (G.L.B.), Mazabuka, Zambia; NYU Comprehensive Epilepsy Center (J.A.F.), New York, NY; Clinical Pharmacology Unit (E.P.), University of Pavia and Institute of Neurology IRCCS C Mondino Foundation, Pavia, Italy; Department of Neurology (D.M.S.), Mount Sinai School of Medicine, New York, NY; Division of Infectious Diseases (H.F.), Cooper..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"George","sequence":"additional","affiliation":[{"name":"From the International Neurologic & Psychiatric Epidemiology Program (G.L.B.), Michigan State University, East Lansing; Epilepsy Care Team, Chikankata Hospital (G.L.B.), Mazabuka, Zambia; NYU Comprehensive Epilepsy Center (J.A.F.), New York, NY; Clinical Pharmacology Unit (E.P.), University of Pavia and Institute of Neurology IRCCS C Mondino Foundation, Pavia, Italy; Department of Neurology (D.M.S.), Mount Sinai School of Medicine, New York, NY; Division of Infectious Diseases (H.F.), Cooper..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.F.","family":"Okulicz","sequence":"additional","affiliation":[{"name":"From the International Neurologic & Psychiatric Epidemiology Program (G.L.B.), Michigan State University, East Lansing; Epilepsy Care Team, Chikankata Hospital (G.L.B.), Mazabuka, Zambia; NYU Comprehensive Epilepsy Center (J.A.F.), New York, NY; Clinical Pharmacology Unit (E.P.), University of Pavia and Institute of Neurology IRCCS C Mondino Foundation, Pavia, Italy; Department of Neurology (D.M.S.), Mount Sinai School of Medicine, New York, NY; Division of Infectious Diseases (H.F.), Cooper..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.B.","family":"Clifford","sequence":"additional","affiliation":[{"name":"From the International Neurologic & Psychiatric Epidemiology Program (G.L.B.), Michigan State University, East Lansing; Epilepsy Care Team, Chikankata Hospital (G.L.B.), Mazabuka, Zambia; NYU Comprehensive Epilepsy Center (J.A.F.), New York, NY; Clinical Pharmacology Unit (E.P.), University of Pavia and Institute of Neurology IRCCS C Mondino Foundation, Pavia, Italy; Department of Neurology (D.M.S.), Mount Sinai School of Medicine, New York, NY; Division of Infectious Diseases (H.F.), Cooper..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Hachad","sequence":"additional","affiliation":[{"name":"From the International Neurologic & Psychiatric Epidemiology Program (G.L.B.), Michigan State University, East Lansing; Epilepsy Care Team, Chikankata Hospital (G.L.B.), Mazabuka, Zambia; NYU Comprehensive Epilepsy Center (J.A.F.), New York, NY; Clinical Pharmacology Unit (E.P.), University of Pavia and Institute of Neurology IRCCS C Mondino Foundation, Pavia, Italy; Department of Neurology (D.M.S.), Mount Sinai School of Medicine, New York, NY; Division of Infectious Diseases (H.F.), Cooper..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.H.","family":"Levy","sequence":"additional","affiliation":[{"name":"From the International Neurologic & Psychiatric Epidemiology Program (G.L.B.), Michigan State University, East Lansing; Epilepsy Care Team, Chikankata Hospital (G.L.B.), Mazabuka, Zambia; NYU Comprehensive Epilepsy Center (J.A.F.), New York, NY; Clinical Pharmacology Unit (E.P.), University of Pavia and Institute of Neurology IRCCS C Mondino Foundation, Pavia, Italy; Department of Neurology (D.M.S.), Mount Sinai School of Medicine, New York, NY; Division of Infectious Diseases (H.F.), Cooper..."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_8_2_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a117441"},{"key":"e_1_3_8_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2007.05.017"},{"key":"e_1_3_8_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1990.00530060048015"},{"key":"e_1_3_8_5_2","first-page":"682","article-title":"Initial burden of disease estimates for South Africa, 2000","volume":"93","author":"Bradshaw D","year":"2003","unstructured":"Bradshaw D, Groenewald P, Laubscher R , et al. Initial burden of disease estimates for South Africa, 2000 S Afr Med J 2003; 93: 682\u2013 688.","journal-title":"S Afr Med J"},{"key":"e_1_3_8_6_2","volume-title":"Patient Monitoring Guidelines for HIV Care and Antiretroviral Therapy.","author":"World Health Organization.","year":"2006","unstructured":"World Health Organization. Patient Monitoring Guidelines for HIV Care and Antiretroviral Therapy. Geneva: WHO Press; 2006."},{"key":"e_1_3_8_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/MAJ.0b013e31814a586a"},{"key":"e_1_3_8_8_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200666180-00003"},{"key":"e_1_3_8_9_2","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.4.5.821"},{"key":"e_1_3_8_10_2","volume-title":"Tuberculosis Care With TB-HIV Co-management.","author":"World Health Organization.","year":"2007","unstructured":"World Health Organization. Tuberculosis Care With TB-HIV Co-management. Geneva: WHO Press; 2007."},{"key":"e_1_3_8_11_2","doi-asserted-by":"crossref","unstructured":"Epilepsy and HIV: a dangerous combination. Lancet Neurol 2007; 6: 747.","DOI":"10.1016\/S1474-4422(07)70197-7"},{"key":"e_1_3_8_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2007.01060_10.x"},{"key":"e_1_3_8_13_2","volume-title":"Clinical Practice Guideline Process Manual: 2004 Edition.","author":"American Academy of Neurology.","year":"2005","unstructured":"American Academy of Neurology. Clinical Practice Guideline Process Manual: 2004 Edition. St. Paul, MN: American Academy of Neurology; 2005."},{"key":"e_1_3_8_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(89)80693-X"},{"key":"e_1_3_8_15_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.56.5.609"},{"key":"e_1_3_8_16_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2009.80.669"},{"key":"e_1_3_8_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200003310-00017"},{"key":"e_1_3_8_18_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.58.12.1764"},{"key":"e_1_3_8_19_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000218303.48113.5d"},{"key":"e_1_3_8_20_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2010.76"},{"key":"e_1_3_8_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2008.106"},{"key":"e_1_3_8_22_2","doi-asserted-by":"publisher","DOI":"10.1177\/0091270009345689"},{"key":"e_1_3_8_23_2","doi-asserted-by":"publisher","DOI":"10.1177\/0091270007310382"},{"key":"e_1_3_8_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1994.137"},{"key":"e_1_3_8_25_2","doi-asserted-by":"publisher","DOI":"10.1186\/1742-6405-8-18"},{"key":"e_1_3_8_26_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1G630"},{"key":"e_1_3_8_27_2","doi-asserted-by":"publisher","DOI":"10.1086\/523722"},{"key":"e_1_3_8_28_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200012010-00022"},{"key":"e_1_3_8_29_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.0306-5251.2003.01919.x"},{"key":"e_1_3_8_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.11.4328-4331.2004"},{"key":"e_1_3_8_31_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-200007000-00009"},{"key":"e_1_3_8_32_2","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.38.302"},{"key":"e_1_3_8_33_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.19211"},{"key":"e_1_3_8_34_2","doi-asserted-by":"publisher","DOI":"10.1592\/phco.20.9.851.35206"},{"key":"e_1_3_8_35_2","volume-title":"Proceedings from the 10th Conference on Retroviruses and Opportunistic Infections","author":"Lim ML","unstructured":"Lim ML, Min SS, Eron JJ , et al. A two-way drug interaction between lopinavir\/ritonavir and phenytoin. In: Proceedings from the 10th Conference on Retroviruses and Opportunistic Infections; Feb 10\u201314, 2003; Boston, MA. Abstract 535."},{"key":"e_1_3_8_36_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.10039"},{"key":"e_1_3_8_37_2","first-page":"406","article-title":"Interaccion Indinavir-Fenitoina en un paciente VIH+: a proposito de un caso","volume":"24","author":"Olmedilla ML","year":"2000","unstructured":"Olmedilla ML, Fernandez AH, Merino GC . Interaccion Indinavir-Fenitoina en un paciente VIH+: a proposito de un caso. Farm Hosp 2000; 24: 406\u2013 407.","journal-title":"Farm Hosp"},{"key":"e_1_3_8_38_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1G418"},{"key":"e_1_3_8_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2006.04.014"},{"key":"e_1_3_8_40_2","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200408150-00006"},{"key":"e_1_3_8_41_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200201250-00009"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.0b013e31823efcf8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T09:49:16Z","timestamp":1711619356000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.0b013e31823efcf8"}},"subtitle":["Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Ad Hoc Task Force of the Commission on Therapeutic Strategies of the International League Against Epilepsy"],"short-title":[],"issued":{"date-parts":[[2012,1,10]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,1,10]]}},"alternative-id":["10.1212\/WNL.0b013e31823efcf8"],"URL":"https:\/\/doi.org\/10.1212\/wnl.0b013e31823efcf8","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,10]]}}}